Crescent Biopharma management scheduled for September investor conferences
Crescent Biopharma said management is scheduled to present at September investor conferences, according to a company announcement.
WALTHAM, Mass., Sept.
03, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) NASDAQ:CBIO, a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the…